Bank of America’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-308,007
| Closed | -$11.8M | – | 8114 |
|
|
2023
Q2 | $11.8M | Sell |
308,007
-6,668
| -2% | -$171K | ﹤0.01% | 2548 |
|
|
2023
Q1 | $7.28M | Buy |
314,675
+139,652
| +80% | +$3.33M | ﹤0.01% | 3143 |
|
|
2022
Q4 | $4.59M | Buy |
175,023
+35,910
| +26% | +$796K | ﹤0.01% | 3462 |
|
|
2022
Q3 | $2.73M | Buy |
139,113
+54,819
| +65% | +$1.1M | ﹤0.01% | 4001 |
|
|
2022
Q2 | $1.48M | Buy |
84,294
+18,171
| +27% | +$285K | ﹤0.01% | 4563 |
|
|
2022
Q1 | $1.08M | Sell |
66,123
-151,662
| -70% | -$2.06M | ﹤0.01% | 5155 |
|
|
2021
Q4 | $3.55M | Buy |
217,785
+1,373
| +0.6% | +$19.5K | ﹤0.01% | 4003 |
|
|
2021
Q3 | $2.76M | Sell |
216,412
-58
| -0% | -$763 | ﹤0.01% | 4136 |
|
|
2021
Q2 | $3.06M | Buy |
216,470
+52,259
| +32% | +$836K | ﹤0.01% | 3964 |
|
|
2021
Q1 | $2.55M | Buy |
164,211
+6,116
| +4% | +$99.7K | ﹤0.01% | 4041 |
|
|
2020
Q4 | $2.51M | Buy |
158,095
+157,900
| +80,974% | +$2.38M | ﹤0.01% | 3746 |
|
|
2020
Q3 | $2K | Sell |
195
-838
| -81% | -$11.2K | ﹤0.01% | 6726 |
|
|
2020
Q2 | $12K | Buy |
1,033
+849
| +461% | +$11.7K | ﹤0.01% | 6401 |
|
|
2020
Q1 | $3K | Sell |
184
-6,615
| -97% | -$78.2K | ﹤0.01% | 6598 |
|
|
2019
Q4 | $40K | Sell |
6,799
-3,362
| -33% | -$18.3K | ﹤0.01% | 6319 |
|
|
2019
Q3 | $54K | Buy |
10,161
+191
| +2% | +$1.27K | ﹤0.01% | 6299 |
|
|
2019
Q2 | $77K | Sell |
9,970
-1,399
| -12% | -$21.3K | ﹤0.01% | 6120 |
|
|
2019
Q1 | $227K | Sell |
11,369
-26,935
| -70% | -$470K | ﹤0.01% | 5460 |
|
|
2018
Q4 | $505K | Buy |
38,304
+21,108
| +123% | +$422K | ﹤0.01% | 4925 |
|
|
2018
Q3 | $632K | Buy |
17,196
+9,768
| +132% | +$314K | ﹤0.01% | 4793 |
|
|
2018
Q2 | $260K | Buy |
7,428
+4,393
| +145% | +$168K | ﹤0.01% | 5268 |
|
|
2018
Q1 | $141K | Sell |
3,035
-22,900
| -88% | -$838K | ﹤0.01% | 5552 |
|
|
2017
Q4 | $972K | Buy |
25,935
+21,409
| +473% | +$935K | ﹤0.01% | 4507 |
|
|
2017
Q3 | $241K | Buy |
4,526
+2,069
| +84% | +$123K | ﹤0.01% | 5297 |
|
|
2017
Q2 | $140K | Sell |
2,457
-303
| -11% | -$15.2K | ﹤0.01% | 5471 |
|
|
2017
Q1 | $149K | Sell |
2,760
-4,683
| -63% | -$265K | ﹤0.01% | 5445 |
|
|
2016
Q4 | $424K | Buy |
7,443
+6,367
| +592% | +$385K | ﹤0.01% | 4911 |
|
|
2016
Q3 | $66K | Sell |
1,076
-4,859
| -82% | -$343K | ﹤0.01% | 5620 |
|
|
2016
Q2 | $336K | Buy |
5,935
+763
| +15% | +$46.4K | ﹤0.01% | 4921 |
|
|
2016
Q1 | $332K | Sell |
5,172
-4,381
| -46% | -$354K | ﹤0.01% | 4863 |
|
|
2015
Q4 | $1.34M | Buy |
9,553
+4,281
| +81% | +$581K | ﹤0.01% | 4144 |
|
|
2015
Q3 | $511K | Buy |
5,272
+3,743
| +245% | +$446K | ﹤0.01% | 4786 |
|
|
2015
Q2 | $232K | Buy |
+1,529
| New | +$252K | ﹤0.01% | 5172 |
|
Bank of America's KDNY Position: Q3 2023 in Review
Bank of America sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 308,007 shares — an estimated $11.8M sold.
Bank of America first reported a position in KDNY in Q2 2015 and held it in 33 quarters. The position peaked at $11.8M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.
- Bank of America reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Bank of America sold 308,007 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $11.8M.
- Bank of America first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2015 and held it in 33 quarters.
- Bank of America's Chinook Therapeutics, Inc. Common Stock position peaked at $11.8M in Q2 2023.
- 2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.
Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.